Vivos Therapeutics (VVOS) EBITDA (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly EBITDA of -$6.6 million for Q1 2026, down 68.84% year-over-year from -$21.2 million in Q1 2025, and down 3.65% quarter-over-quarter from -$6.4 million in Q4 2025.
Vivos Therapeutics (VVOS) EBITDA (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported EBITDA for 7 consecutive years, with -$6.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA fell 68.84% year-over-year to -$6.6 million; the TTM figure through Mar 2026 stood at -$22.6 million (down 99.88% YoY), while the FY2025 annual figure was -$19.9 million, down 78.09% from the prior year.
- EBITDA eased to -$6.6 million in Q1 2026 per VVOS's latest filing, from -$6.4 million in the prior quarter.
- Across five years, EBITDA topped out at -$1.9 million in Q2 2024 and bottomed at -$7.0 million in Q2 2022.
- Historically, EBITDA has averaged -$4.7 million across 5 years, with a median of -$4.7 million in 2025.
- Annual changes were most pronounced in 2024 — EBITDA jumped 57.14% — and 2025, when it tumbled 151.29%.
- Vivos Therapeutics' EBITDA stood at -$6.1 million in 2022, then surged by 31.83% to -$4.1 million in 2023, then jumped by 32.11% to -$2.8 million in 2024, then tumbled by 127.44% to -$6.4 million in 2025, then decreased by 3.65% to -$6.6 million in 2026.
- Business Quant data shows VVOS's EBITDA at -$6.6 million in Q1 2026, -$6.4 million in Q4 2025, and -$4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 285.80 Mn |
| 10 | Vivos Therapeutics | 4.81 Mn | 3.01 Mn | 2.95 Mn | -4.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.62 Mn |
| Dec 31, 2025 | -6.38 Mn |
| Sep 30, 2025 | -4.73 Mn |
| Jun 30, 2025 | -4.87 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -2.81 Mn |
| Sep 30, 2024 | -2.65 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -3.79 Mn |
| Dec 31, 2023 | -4.13 Mn |
| Sep 30, 2023 | -3.64 Mn |
| Jun 30, 2023 | -4.52 Mn |
| Mar 31, 2023 | -5.01 Mn |
| Dec 31, 2022 | -6.06 Mn |
| Sep 30, 2022 | -5.41 Mn |
| Jun 30, 2022 | -6.96 Mn |
| Mar 31, 2022 | -6.64 Mn |
| Dec 31, 2021 | -7.41 Mn |
| Sep 30, 2021 | -5.50 Mn |
| Jun 30, 2021 | -4.06 Mn |